Ian P Keary

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Respiratory Syncytial Virus

Low Birth Weight

Preterm Infants

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Barry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, Ian P Keary, Jean-Eric Tarride, Bosco A Paes
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants. Journal of medical economics (2023)
Ian P Keary, Roberto Ravasio, John R Fullarton, Paolo Manzoni, Marcello Lanari, Bosco A Paes, Xavier Carbonell-Estrany, Eugenio Baraldi, Jean-Éric Tarride, Barry S Rodgers-Gray
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age. PloS one 18 (8) (2023)